Symbol: |
THADA
|
Description: |
thyroid adenoma associated [Source:HGNC Symbol;Acc:19217]
|
Location: |
Chr2:43393800-43823185[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:138
Gene |
Compound |
Gen_sig |
Exp_pattern |
THADA |
NSC 105348 |
0.031 |
Up |
THADA |
Cromolyn sodium |
0.047 |
Up |
THADA |
NSC 113491 |
0.03 |
Down |
THADA |
D-Amethopterin |
0.01 |
Down |
THADA |
NSC 119621 |
0.019 |
Up |
THADA |
Geldanamicin |
0.025 |
Down |
THADA |
Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) |
0.003 |
Down |
THADA |
Ethanesulfonic acid, compd. with 2-(2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenoxy)acetanilide (1:1) |
0.042 |
Down |
THADA |
Ethanesulfonic acid, compd. with 4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)-m-hydrocinnamotoluidide (1:1) |
0.005 |
Down |
THADA |
NSC 135371 |
0.024 |
Down |
THADA |
Ethanesulfonic acid, compd. with 2-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]acetanilide (1:1) |
0.004 |
Down |
THADA |
TZT |
0.035 |
Down |
THADA |
Phosphinic amide, P,P-bis(1-aziridinyl)-N-tricyclo[3.3.1.1(3.7)]dec-1-yl- |
0.036 |
Down |
THADA |
7H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile, 4-amino-6-hydrazino-7-.beta.-D-ribofuranosyl- |
0.003 |
Down |
THADA |
L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate |
0.028 |
Down |
Expression pattern: Sensitivity / Resistance
Total:10 Current:1
[First] [Prev]  Next Last 
|
SNP:
~ Export ~
|
Records:17
Total:2 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:16
Total:2 Current:1
[First] [Prev]  Next Last 
|